Product Images Zoledronic Acid
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Zoledronic Acid NDC 55150-266 by Auromedics Pharma Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - zoledronic acid fig1
The text describes a figure showing the proportion of complete responders by day 10 in two different studies involving Zoledronic Acid and Pamidronate. The figure displays a graph with percentages of complete responders on the y-axis and the days on the x-axis. The pooled HCM studies show that the Zoledronic Acid group had a 100% complete response rate compared to 80% in the Pamidronate group. There was also a statistically significant difference between the two groups (P=0.002).*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg per 5 mL (0.8 mg / mL) - Container Label - zoledronic acid fig2
This text is a description of a pharmaceutical product. The product is a sterile, non-pyrogenic solution that comes in a 5mL single-dose vial with NDC code 55150-266-05. It is for intravenous infusion only after dilution, as the dose must be diluted. It should not be mixed with calcium-containing solutions, such as zoledronic infusion solutions. The product is not for direct injection and must be discarded if unused. It is manufactured in India for AuroMedics Pharma LLC in E. Windsor, NJ. The solution has 3% of 4mg per 5mL and a concentration of 0.08mg/mL. It should be stored at room temperature between 20° to 25°C (68° to 77°F) and the unused portions should be discarded.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg per 5 mL (0.8 mg / mL) - Container-Carton (1 Vial) - zoledronic acid fig3
This is a medication label for a single-dose vial of Zoledronic Acid Injection, which can be used for intravenous infusion after dilution. The medication must not be administered directly and must be diluted before use. The package comes in a 5mL vial, and any unused portion must be discarded. Dosage information is provided, as well as the NDC number for prescription purposes. Some portions of the text are not legible due to issues.*
Zoledronic Acid Monohydrate Chemical Structure - zoledronic acid str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.